Recent experimental and clinical data demonstrate a significant dysregulation of the gut
microbiome in individuals with Parkinson's disease (PD). With an immense influence on all …

Ageing is inevitable and poses a universal challenge for all living organisms, including
humans. The human body experiences rapid cell division and metabolism until …

It is now well recognized that a bidirectional relationship between gut microbiota and the
brain, referred to as the gut-brain axis, plays a prominent role in maintaining homeostasis …

Parkinson's disease (PD) is the second most common neurodegenerative disease in the
world, severely affecting the quality of life of patients. Recent studies have shown that white …

Neurodegenerative diseases (NDDs), characterized by the progressive deterioration of the
structure and function of the nervous system, represent a significant global health challenge …

There is increasing evidence that microbial-based therapies can be useful in people with
Parkinson's disease (PD). In this viewpoint, we provide a state-of-the-art review of the …

Gut microbiome-targeted interventions such as fecal transplant, prebiotics, probiotics,
synbiotics, and antibiotic gut depletion are speculated to be of potential use in delaying the …

The existing data demonstrate that probiotic supplementation affords protective effects
against neurotoxicity of exogenous (eg, metals, ethanol, propionic acid, aflatoxin B1, organic …